Peculiaritie of Distribution of Polymorphic Variants of IL1Β Gene in Patients with Atherosclerosis and Metabolic Syndrome

Q4 Pharmacology, Toxicology and Pharmaceutics
Saranchina Yuliya Vladimirovna, Rossova N. Aleksandrovna, Khanarin Nikolaj Vladimirovich, Kilina Oksana Yurevna, Dutova Svetlana Vyacheslavovna, Kulakova Tatyana Sergeevna
{"title":"Peculiaritie of Distribution of Polymorphic Variants of IL1Β Gene in Patients with Atherosclerosis and Metabolic Syndrome","authors":"Saranchina Yuliya Vladimirovna, Rossova N. Aleksandrovna, Khanarin Nikolaj Vladimirovich, Kilina Oksana Yurevna, Dutova Svetlana Vyacheslavovna, Kulakova Tatyana Sergeevna","doi":"10.2174/1875692117666190416150346","DOIUrl":null,"url":null,"abstract":"\n\nThe purpose of the study was to analyze the association of allelic\npolymorphism of IL1В gene C>T loci -31 and +3953 with atherosclerotic changes of\nartries in patients with Metabolic Syndrome (MS).\n\n\n\nThe main group of the study included 30 consecutive patients\n(24 women and 6 men, mean age - 51.7±2.2 years), for examination and treatment in the\ntherapeutic Department of the Republican clinical hospital named \"G. YA. Remishevskaya\"\n(Abakan) about arterial hypertension or suspicion of type 2 diabetes. The criteria for inclusion\nin the core group included: compliance with the MS criteria according to the IDF criteria\n(2006); and the presence of ultrasound markers of Atherosclerosis (AS) according to\nthe study of brachiocephalic arteries (presence of Atherosclerotic Plaques (ASP) and\nstenosis ≥30%). The control group included persons who underwent a planned medical\nexamination in the Republican clinical hospital name \"G. YA. Remishevskaya\" (Abakan).\nA total of 35 patients (26 women and 9 men, mean age 44.7±1.5 years) were selected. The\nstudy involved the Russian population (Caucasians) living in the territory of the Republic\nof Khakassia. All the necessary examination and data collection were conducted including\nanamnestic data, anthropometric examination (measurements of length and body mass,\nwaist circumference) body mass index, laboratory examination of blood biochemical parameters\n(glucose and lipid) and instrumental examination (blood pressure measurement,\nconducting ECG and ultrasound the brachiocephalic arteries). Single-nucleotide polymorphisms\n(SNP) of the promoter region of the IL1B gene at position-31C/T (rs1143627) and\npolymorphism in the coding part of the gene in exon 5 +3953C/T (rs 1143634) were studied\nby restriction analysis of amplification products (RFLP analysis).\n\n\n\nThe risk of development of AS in patients with MS may be higher in carriers of\ngenotype TT (OR = 1,76; 95% CI: (0,96-3,24)) or T allele (OR = 1,44; 95% CI: (0,82-\n2,53)) IL1В gene in the polymorphic locus of the T-31С and genotype CT (OR = 1,85;\n95% CI: (0,92-3,37)) or T allele (OR = 1,35; 95% CI: (0,63-2,89)) IL1В gene in the\npolymorphic locus of C + 3953T. The most common combination of gene polymorphisms\nIL1В was haplotype (-31) ТC/(+3953)СС in both the groups surveyed (40.6% to 36.8%,\nrespectively). Variant (-31)TT/(+3953)CT in the main group was found significantly more\noften (15.8%, at χ2= 4.92, at p=0.03) than in the control group (3.1 %). The value of the\nodds ratio in this case was 3.99 (95% CI: (1.08-14.79), which indicates the risk of AS development\nagainst the background of MS in carriers of combined genotype inheritance\n(-31)TT/(+3953) CT.\n\n\n\nThe risk of development of AS in the background of MS is increased in\ncarriers of combinations of SNPs (-31)TT/(+3953)CT IL1В gene responsible for hyperproduction\nof this cytokine. In this connection, further studies of the association of genes\nwith MS and AS components should focus on intergenic interactions.\n","PeriodicalId":11056,"journal":{"name":"Current Pharmacogenomics and Personalized Medicine","volume":"26 1","pages":"32-39"},"PeriodicalIF":0.0000,"publicationDate":"2020-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Pharmacogenomics and Personalized Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1875692117666190416150346","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

The purpose of the study was to analyze the association of allelic polymorphism of IL1В gene C>T loci -31 and +3953 with atherosclerotic changes of artries in patients with Metabolic Syndrome (MS). The main group of the study included 30 consecutive patients (24 women and 6 men, mean age - 51.7±2.2 years), for examination and treatment in the therapeutic Department of the Republican clinical hospital named "G. YA. Remishevskaya" (Abakan) about arterial hypertension or suspicion of type 2 diabetes. The criteria for inclusion in the core group included: compliance with the MS criteria according to the IDF criteria (2006); and the presence of ultrasound markers of Atherosclerosis (AS) according to the study of brachiocephalic arteries (presence of Atherosclerotic Plaques (ASP) and stenosis ≥30%). The control group included persons who underwent a planned medical examination in the Republican clinical hospital name "G. YA. Remishevskaya" (Abakan). A total of 35 patients (26 women and 9 men, mean age 44.7±1.5 years) were selected. The study involved the Russian population (Caucasians) living in the territory of the Republic of Khakassia. All the necessary examination and data collection were conducted including anamnestic data, anthropometric examination (measurements of length and body mass, waist circumference) body mass index, laboratory examination of blood biochemical parameters (glucose and lipid) and instrumental examination (blood pressure measurement, conducting ECG and ultrasound the brachiocephalic arteries). Single-nucleotide polymorphisms (SNP) of the promoter region of the IL1B gene at position-31C/T (rs1143627) and polymorphism in the coding part of the gene in exon 5 +3953C/T (rs 1143634) were studied by restriction analysis of amplification products (RFLP analysis). The risk of development of AS in patients with MS may be higher in carriers of genotype TT (OR = 1,76; 95% CI: (0,96-3,24)) or T allele (OR = 1,44; 95% CI: (0,82- 2,53)) IL1В gene in the polymorphic locus of the T-31С and genotype CT (OR = 1,85; 95% CI: (0,92-3,37)) or T allele (OR = 1,35; 95% CI: (0,63-2,89)) IL1В gene in the polymorphic locus of C + 3953T. The most common combination of gene polymorphisms IL1В was haplotype (-31) ТC/(+3953)СС in both the groups surveyed (40.6% to 36.8%, respectively). Variant (-31)TT/(+3953)CT in the main group was found significantly more often (15.8%, at χ2= 4.92, at p=0.03) than in the control group (3.1 %). The value of the odds ratio in this case was 3.99 (95% CI: (1.08-14.79), which indicates the risk of AS development against the background of MS in carriers of combined genotype inheritance (-31)TT/(+3953) CT. The risk of development of AS in the background of MS is increased in carriers of combinations of SNPs (-31)TT/(+3953)CT IL1В gene responsible for hyperproduction of this cytokine. In this connection, further studies of the association of genes with MS and AS components should focus on intergenic interactions.
动脉粥样硬化和代谢综合征患者IL1Β基因多态性变异分布的特殊性
本研究的目的是分析IL1В基因C>T位点-31和+3953等位基因多态性与代谢综合征(MS)患者动脉粥样硬化改变的关系。本研究的主要组包括30例连续患者,其中女性24例,男性6例,平均年龄- 51.7±2.2岁,在中华人民共和国临床医院治疗科接受检查和治疗。Remishevskaya“(Abakan)关于动脉高血压或2型糖尿病的怀疑。纳入核心组的标准包括:根据IDF标准(2006年)符合MS标准;根据头臂动脉的研究,存在动脉粥样硬化(AS)的超声标志物(存在动脉粥样硬化斑块(ASP)和狭窄≥30%)。对照组包括在名为“g.ya”的共和临床医院接受计划体检的人。Remishevskaya”(亚巴坎)。共35例患者,其中女性26例,男性9例,平均年龄44.7±1.5岁。该研究涉及居住在哈萨克斯坦共和国领土上的俄罗斯人口(高加索人)。所有必要的检查和资料收集都进行了,包括记忆资料、人体测量(测量身高、体重、腰围)、体重指数、血液生化参数(血糖、血脂)的实验室检查和仪器检查(测量血压、进行心电、超声检查头臂动脉)。利用扩增产物限制性内切分析(RFLP)研究了IL1B基因- 31c /T启动子区域(rs1143627)的单核苷酸多态性(SNP)和该基因外显子5 +3953C/T编码部分(rs1143634)的多态性。TT基因型携带者的MS患者发生AS的风险可能更高(OR = 1,76;95% CI:(0,96-3,24))或T等位基因(or = 1,44;95% CI:(0.82 -2,53)) T-31С和基因型CT (OR = 1.85;95% CI:(0.92 -3,37))或T等位基因(OR = 1.35;C + 3953T多态性位点的95% CI为(0,63-2,89))IL1В基因。基因polymorphismsIL1В最常见的组合是单倍型(-31)ТC/(+3953)СС(分别为40.6% ~ 36.8%)。主组TT变异(-31)/ CT变异(+3953)的发生率(15.8%,χ2= 4.92, p=0.03)明显高于对照组(3.1%)。该病例的优势比为3.99 (95% CI: 1.08 ~ 14.79),表明合并基因型遗传携带者在MS背景下发生AS的风险为(-31)TT/(+3953) CT。在MS背景下,携带snp (-31)TT/(+3953)CT IL1В基因组合的患者发生AS的风险增加。在这方面,进一步研究基因与MS和AS组分的关联应侧重于基因间相互作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current Pharmacogenomics and Personalized Medicine
Current Pharmacogenomics and Personalized Medicine Pharmacology, Toxicology and Pharmaceutics-Pharmacology
CiteScore
0.40
自引率
0.00%
发文量
11
期刊介绍: Current Pharmacogenomics and Personalized Medicine (Formerly ‘Current Pharmacogenomics’) Current Pharmacogenomics and Personalized Medicine (CPPM) is an international peer reviewed biomedical journal that publishes expert reviews, and state of the art analyses on all aspects of pharmacogenomics and personalized medicine under a single cover. The CPPM addresses the complex transdisciplinary challenges and promises emerging from the fusion of knowledge domains in therapeutics and diagnostics (i.e., theragnostics). The journal bears in mind the increasingly globalized nature of health research and services.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信